Vitiligo Treatment in Kuwait
Vitiligo is an autoimmune disease in which the immune system attacks the pigment-producing cells, leaving sharply defined white patches. Treatment works, and works well in certain sites, but results vary enormously with the location of the patch and how long it has been there.
What you should know
- Vitiligo affects 0.5% to 2% of the population; the average age of onset is between 20 and 24, and 80% of all cases appear before the age of 30.
- Vitiligo is an autoimmune disease, not an infection; it does not spread by contact, by shaking hands, or by sharing personal items — this is the first point I clarify with a patient's family.
- Vitiligo is associated with autoimmune thyroid disease in up to 15% of affected adults and 5% to 10% of affected children, which is why I check thyroid function routinely at diagnosis.
- The patches are far more conspicuous in darker skin because of the sharp colour contrast, which makes the psychological and social burden considerably heavier for our patients in the Gulf — and that is a genuine factor in treatment decisions.
- The face and neck respond better than the trunk, the trunk responds better than the limbs, and response on the hands and feet is very poor indeed — a fact I set out plainly before starting any plan.
- Features that predict a poorer response include longstanding disease, white hairs within the patch, mucosal involvement, and new patches appearing at sites of friction or injury.
Treatment options
- Topical corticosteroids for up to three months on the trunk and limbs, while I prefer topical calcineurin inhibitors for the face, eyelids and neck because they do not cause skin atrophy with prolonged use on these delicate sites.
- Narrowband UVB phototherapy twice weekly for a trial period of three to four months; a marked or clinically useful response was achieved in 36% of patients at twelve months — so a good response in roughly a third, not in everyone.
- Ruxolitinib cream, a JAK inhibitor: 75% repigmentation of the face in 29.8% and 30.9% of patients at week 24, versus 7.4% and 11.4% on vehicle, across two trials enrolling 674 patients.
- Surgical melanocyte transplantation or grafting for stable disease, particularly segmental vitiligo that has stopped spreading; this is an option for carefully selected patients, not for everyone.
- Cosmetic camouflage and daily sun protection; the patches contain no melanin and burn far more readily, which makes this a medical necessity under the Kuwaiti sun rather than a cosmetic matter.
The single most important thing to understand is that relapse is common after treatment stops. Treatments that block the immune pathway genuinely do restore pigment, but resident memory immune cells persist in the skin and attack the pigment cells again once treatment ends. We therefore usually plan a maintenance phase — and no treatment available today can guarantee that new patches will not appear.
Your first vitiligo visit
- I examine the skin under a Wood’s lamp to map the patches and their activity; it sometimes shows patches the eye cannot see.
- I determine the type (non-segmental or segmental) and whether it is active, because treatment and expectations differ between them.
- We take standardised photos of the patches so that results can be compared objectively after 3–4 months.
- I order a thyroid test, then we set a plan for each body area with realistic goals.
Practical advice for patients
The practical points from the patient sheet I hand out in clinic.
- Vitiligo is an immune condition in which some pigment cells lose their colour; it is not contagious, not painful, and does not affect general health.
- Early treatment gives better results, especially on the face — don't delay review when new patches appear.
- Effective options exist: creams (including a new JAK-inhibitor cream), phototherapy (narrow-band UVB), and surgical options for stable cases — discuss what suits you.
- Use SPF 50+ sunscreen on the white patches — they burn quickly, and protecting normal skin from tanning reduces the colour contrast.
- Avoid skin injury and strong friction (scratching, rubbing, tight clothes) — trauma can trigger new patches.
- Results are slow and need months: the face responds best; hands and feet are slowest — patience is part of the treatment.
- Check thyroid function periodically — vitiligo can be associated with autoimmune thyroid disease.
- Camouflage and cover products are safe and available; do not trust unproven folk remedies.
- Psychological support matters — vitiligo does not prevent a full, normal life.
Frequently asked questions
Is vitiligo contagious?
No, not at all. Vitiligo is an autoimmune disease in which the immune system attacks the skin's pigment cells; it is not a bacterial, viral or fungal infection. It does not pass by contact, handshakes, sharing items, or swimming in the same pool.
Does vitiligo come back after successful treatment?
Yes — relapse is common after stopping treatment. The reason is that resident memory immune cells remain in the skin and resume attacking the pigment cells once treatment ends. This is why we discuss maintenance treatment from the outset rather than stopping everything the moment colour returns.
Why are my hands not responding when my face has improved?
This is an expected pattern, not a treatment failure. Face and neck respond better than trunk, trunk better than limbs, and the hands and feet respond very poorly because they have few hair follicles, which are the reservoir the pigment cells repopulate from. So we set different goals for different sites.
How long does phototherapy take before we know it is working?
We allow a trial period of three to four months at two sessions per week. If repigmentation appears we continue, potentially for one to two years. If there is no response at all during the trial period, it is more honest to change the plan than to continue without benefit.
Does eating fish with milk or yoghurt cause vitiligo?
No. It is a common belief, but there is no scientific evidence that any food, or combination of foods, causes or worsens vitiligo. Vitiligo is an autoimmune condition; there is no special vitiligo diet, and regular treatment with sun protection matters far more.
Is vitiligo hereditary? Will my children get it?
Genes play a part, but they are not the whole story. In the largest family study (more than 2,600 patients), only about 6% of patients’ siblings had vitiligo, and even identical twins were both affected in only about a quarter of cases. Most relatives and children of people with vitiligo never develop it.
Can vitiligo be treated in children?
Yes. We usually start with creams — calcineurin inhibitors for the face and an age-appropriate cortisone for limited periods on the body. Phototherapy is possible for older children who can keep up with the sessions, and emotional support and sun protection are part of treatment.
About the author: Dr. Abdulaziz AlRashed is a consultant dermatologist, cosmetic & laser specialist in Kuwait with 20+ years of experience — European Board of Dermatology & Venereology and MSc in Clinical Dermatology (King’s College London). He sees patients at his private clinic at Kuwait Hospital (Sabah Al-Salem). Qualifications & experience
Walk-in clinic – no appointment needed
My private clinic at Kuwait Hospital (Sabah Al-Salem) — walk-in, Sunday to Thursday, 8 am – 4 pm. Direct assessment and a treatment plan built around your case.
Ask on WhatsAppPatient advice sheets
Short, practical sheets to read before or after your visit.